寻找去势抵抗性前列腺癌生存的预测因素。 - Suppr

Suppr

超能文献

Toward predictors of survival in castration-resistant prostate cancer.

作者信息

Graff Julie N, Beer Tomasz M

出版信息

Cancer. 2011 Sep 1;117(17):3882-4. doi: 10.1002/cncr.25986. Epub 2011 Mar 9.

DOI:10.1002/cncr.25986

PMID:21391212

Abstract

摘要

相似文献

Toward predictors of survival in castration-resistant prostate cancer.

Cancer. 2011 Sep 1;117(17):3882-4. doi: 10.1002/cncr.25986. Epub 2011 Mar 9.

Prostate-specific antigen response to deferred combined androgen blockade therapy using bicalutamide predicts survival after subsequent oestrogen and docetaxel therapies in patients with castration-resistant prostate cancer.

BJU Int. 2012 Oct;110(8):1149-55. doi: 10.1111/j.1464-410X.2012.10959.x. Epub 2012 Feb 28.

Salvage therapy with bicalutamide 150 mg in nonmetastatic castration-resistant prostate cancer.

Urology. 2010 Nov;76(5):1189-93. doi: 10.1016/j.urology.2009.12.057. Epub 2010 Mar 29.

Cabazitaxel for castration-resistant prostate cancer.

Lancet. 2011 Jan 8;377(9760):121-2; author reply 122-3. doi: 10.1016/S0140-6736(11)60013-5.

Drug development for metastatic castration-resistant prostate cancer: current status and future perspectives.

Future Oncol. 2011 Apr;7(4):551-8. doi: 10.2217/fon.11.14.

Treatment and survival of patients with cancer of the prostate. The Veterans Administration Co-operative Urological Research Group.

Surg Gynecol Obstet. 1967 May;124(5):1011-7.

Prediction of survival following first-line chemotherapy in men with castration-resistant metastatic prostate cancer.

Clin Cancer Res. 2010 Jan 1;16(1):203-11. doi: 10.1158/1078-0432.CCR-09-2514. Epub 2009 Dec 15.

Time to castration resistance is an independent predictor of castration-resistant prostate cancer survival.

Anticancer Res. 2011 Apr;31(4):1475-82.

[Analysis of prognostic factor in 52 castration-resistant prostate cancer treated with docetaxel].

Hinyokika Kiyo. 2012 Jan;58(1):7-11.

Chemical castration and survival in low-risk prostate cancer.

Eur Urol. 2009 Oct;56(4):617-8. doi: 10.1016/j.eururo.2009.03.067. Epub 2009 Apr 1.

引用本文的文献

The effectiveness of the TAX 327 nomogram in predicting overall survival in Chinese patients with metastatic castration-resistant prostate cancer.

Asian J Androl. 2013 Sep;15(5):679-84. doi: 10.1038/aja.2013.52. Epub 2013 Jul 1.

Pathobiological implications of the expression of EGFR, pAkt, NF-κB and MIC-1 in prostate cancer stem cells and their progenies.

PLoS One. 2012;7(2):e31919. doi: 10.1371/journal.pone.0031919. Epub 2012 Feb 23.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Toward predictors of survival in castration-resistant prostate cancer.

作者信息

Graff Julie N, Beer Tomasz M

出版信息

Cancer. 2011 Sep 1;117(17):3882-4. doi: 10.1002/cncr.25986. Epub 2011 Mar 9.

DOI:10.1002/cncr.25986

PMID:21391212

Abstract

摘要

相似文献

Toward predictors of survival in castration-resistant prostate cancer.

Cancer. 2011 Sep 1;117(17):3882-4. doi: 10.1002/cncr.25986. Epub 2011 Mar 9.

BJU Int. 2012 Oct;110(8):1149-55. doi: 10.1111/j.1464-410X.2012.10959.x. Epub 2012 Feb 28.

Salvage therapy with bicalutamide 150 mg in nonmetastatic castration-resistant prostate cancer.

Urology. 2010 Nov;76(5):1189-93. doi: 10.1016/j.urology.2009.12.057. Epub 2010 Mar 29.

Cabazitaxel for castration-resistant prostate cancer.

Lancet. 2011 Jan 8;377(9760):121-2; author reply 122-3. doi: 10.1016/S0140-6736(11)60013-5.

Drug development for metastatic castration-resistant prostate cancer: current status and future perspectives.

Future Oncol. 2011 Apr;7(4):551-8. doi: 10.2217/fon.11.14.

Treatment and survival of patients with cancer of the prostate. The Veterans Administration Co-operative Urological Research Group.

Surg Gynecol Obstet. 1967 May;124(5):1011-7.

Prediction of survival following first-line chemotherapy in men with castration-resistant metastatic prostate cancer.

Clin Cancer Res. 2010 Jan 1;16(1):203-11. doi: 10.1158/1078-0432.CCR-09-2514. Epub 2009 Dec 15.

Time to castration resistance is an independent predictor of castration-resistant prostate cancer survival.

Anticancer Res. 2011 Apr;31(4):1475-82.

[Analysis of prognostic factor in 52 castration-resistant prostate cancer treated with docetaxel].

Hinyokika Kiyo. 2012 Jan;58(1):7-11.

Chemical castration and survival in low-risk prostate cancer.

Eur Urol. 2009 Oct;56(4):617-8. doi: 10.1016/j.eururo.2009.03.067. Epub 2009 Apr 1.

引用本文的文献

The effectiveness of the TAX 327 nomogram in predicting overall survival in Chinese patients with metastatic castration-resistant prostate cancer.

Asian J Androl. 2013 Sep;15(5):679-84. doi: 10.1038/aja.2013.52. Epub 2013 Jul 1.

Pathobiological implications of the expression of EGFR, pAkt, NF-κB and MIC-1 in prostate cancer stem cells and their progenies.

PLoS One. 2012;7(2):e31919. doi: 10.1371/journal.pone.0031919. Epub 2012 Feb 23.